BioVenture VoiCes

Announcing our next guest on Episode 17 of BioVenture VoiCes video podcast, Tiba Aynechi, General Partner at Norwest. We discuss her 20+ year career from her early focus on computational drug discovery as a PhD in Biophysics at UCSF to early experience facilitating M&A/licensing/financing at a VC/merchant bank to her 12 years leading life science investments at Novo Ventures before joining Norwest to help lead their biotech investment practice. This conversation will be posted early next week on BiotechTV and encourage you to take a listen. Follow BioVenture VoiCes to hear announcements about discussions with successful healthcare VC leaders!

Announcing our next guest on Episode 16 of BioVenture VoiCes video podcast, Joshua Resnick, Partner at RA Capital Management and President of Raven (RA Ventures). We discuss his Venture journey from his dual MD/MBA from University of Pennsylvania (Perelman and Wharton Schools) to multiple Venture firms (Atlas, Merck's MRL Ventures, SV) and company creation experience before joining RA and helping establish the Raven strategy. This conversation will be posted early next week on BiotechTV and encourage you to take a listen. Follow BioVenture VoiCes to hear announcements about discussions with successful healthcare VC leaders!

Announcing our next guest on Episode 15 of BioVenture VoiCes video podcast, Steve Tregay, Managing General Partner of Mission BioCapital. We discuss how he leveraged his training as a chemist and early biotech experiences at Array Biopharma and Forma to the shaping of the LabCentral / BioLabs model of shared spaces and how it supports the early-stage investing model at Mission BioCapital (a merger of former strategies at BioInnovation Capital and Mission Bay Capital). This conversation will be posted early next week on BiotechTV and encourage you to take a listen. Follow BioVenture VoiCes to hear announcements about discussions with successful healthcare VC leaders!

Announcing our guest on Episode 14 of BioVenture VoiCes video podcast, Joe Jimenez, Co-Founder and Managing Director at Aditum Bio. We discuss his journey from business executive at leading consumer products companies into pharma and a fast track to CEO of Novartis to his post-Novartis career in establishing Aditum with former NIBR head Mark Fishman as a unique model of drug development and shared operational support. This conversation will be posted early next week on BiotechTV and encourage you to take a listen. Follow BioVenture VoiCes to hear announcements about discussions with successful healthcare VC leaders!

Announcing our guest on Episode 13 of BioVenture VoiCes video podcast, Shahram Seyedin-Noor, Founder and Managing Partner at Civilization Ventures. We discuss his journey from immigrant to Harvard JD working at top firms supporting tech companies to entrepreneur / early investor to his founding Civilization Ventures with a unique focus on cutting edge tech in healthcare. This conversation will be posted early next week on BiotechTV and encourage you to take a listen. Follow BioVenture VoiCes to hear announcements about discussions with successful healthcare VC leaders!

Announcing our guest on Episode 12 of BioVenture VoiCes video podcast, Avak Kahvejian, General Partner at Flagship Pioneering. We discuss his journey in optimizing and scaling the venture creation and platform technology model at Flagship and the evolution of leading Flagship Venture Labs to the current internal incubation model at the firm. This conversation will be posted early next week on BiotechTV and encourage you to take a listen. Follow BioVenture VoiCes to hear announcements about discussions with successful healthcare VC leaders!

Announcing our guest on Episode 11 of BioVenture VoiCes video podcast, Tony Kulesa, Partner at Pillar VC. We discuss his journey in helping pioneer the recent founder-led biotech movement during his PhD at MIT and the founding of Petri as a seed/pre-seed incubator for scientific entrepreneurs to folded-in as a core strategy of Pillar's biotech investing strategy. This conversation will be posted early next week on BiotechTV and encourage you to take a listen. Follow BioVenture VoiCes to hear announcements about discussions with successful healthcare VC leaders!

𝐁𝐢𝐨𝐕𝐞𝐧𝐭𝐮𝐫𝐞 𝐕𝐨𝐢𝐂𝐞𝐬 𝐰𝐢𝐭𝐡 𝐂𝐡𝐫𝐢𝐬 𝐆𝐚𝐫𝐚𝐛𝐞𝐝𝐢𝐚𝐧: Episode 10 | Curie.Bio's Alexis Borisy. The Co-Founder and Operating Chairman of Curie.Bio, and serial entrepreneur, shares experiences from his early life, CombinatoRx, Foundation Medicine, Third Rock, EQRx and more. Full video: https://lnkd.in/gn7dJjfk BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Allucent | NYSE | Savills

Announcing our guest on Episode 10 of BioVenture VoiCes video podcast, Alexis Borisy, Co-Founder and Operating Chairman of Curie.Bio. We discuss his journey from his early interest in the nexus of science and business to his first founder-led startup in his 20s and his serial entrepreneurship and move into venture capital with Third Rock Ventures and Co-Founding Curie.bio's unique seed investment model to support founder-led startups. This conversation will be posted early next week on BiotechTV and encourage you to take a listen. Follow BioVenture VoiCes to hear announcements about discussions with successful healthcare VC leaders!

𝐁𝐢𝐨𝐕𝐞𝐧𝐭𝐮𝐫𝐞 𝐕𝐨𝐢𝐂𝐞𝐬 𝐰𝐢𝐭𝐡 𝐂𝐡𝐫𝐢𝐬 𝐆𝐚𝐫𝐚𝐛𝐞𝐝𝐢𝐚𝐧: Episode 9 | Alloy Therapeutics, Inc. & 82VS's Errik Anderson. He describes his career path and learnings from the tech industry, co-founding Adimab, the work that Alloy and 82VS do to support and invest in scientist-entrepreneurs, and why he believes smaller organizations are best suited for discovery work and other early stage innovation. Full video: https://lnkd.in/g7zPQhjG BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | NYSE | Allucent | Klein Hersh